TYME Technologies Shares Surge On Merger Agreement With Syros Pharma

  • Syros Pharmaceuticals Inc SYRS has agreed to acquire TYME Technologies Inc TYME, including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately $60 million.
  • Syros expects to issue approximately 74.3 million shares. TYME stockholders are expected to receive approximately 0.4312 shares of Syros shares for each share of TYME share.
  • The combined company will be led by Syros' existing management team, including Nancy Simonian, CEO of Syros. It will focus on advancing Syros' pipeline of small molecule medicines for cancer.
  • Related: Syros' CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies.
  • Concurrent with the merger, Syros announced an oversubscribed $130 million private investment in public equity (PIPE) financing at a price per unit of $0.94. 
  • Following the merger's closing, the combined company's total cash balance is expected to be approximately $240 million, sufficient to fund Syros' planned operating expenses and capital expenditure requirements into 2025.
  • The transactions are expected to close in the second half of 2022.
  • Price Action: SYRS shares closed at $0.91 on Friday. TYME shares are up 46.78% at $0.39 during the premarket session on the last check Tuesday.

Posted In: Briefswhy it's movingBiotechM&ANewsPenny StocksHealth CareMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.